$PCRX
Pacira BioSciences Inc
PRICE
$39.14 -
Extented Hours
VOLUME
695,626
DAY RANGE
37.63 - 39.255
52 WEEK
35.35 - 82.16
Key Metrics
Market Cap
1.80 B
Beta
0.79
Avg. Volume
633.83 K
Shares Outstanding
45.95 M
Yield
0%
Public Float
0
Next Earnings Date
2023-05-04
Next Dividend Date
Company Information
Pacira BioSciences, Inc.is the industry leader in its commitment to non-opioid pain management and regenerative health solutions to improve patients' journeys along the neural pain pathway. The company's long-acting local analgesic, EXPAREL ® (bupivacaine liposome injectable suspension) was commercially launched in the United States in April 2012. EXPAREL utilizes DepoFoam®, a unique and proprietary product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time. In April 2019, Pacira acquired the iovera° system, a handheld cryoanalgesia device used to deliver precise, controlled doses of cold temperature only to targeted nerves.
CEO: David M. Stack
Website: www.pacira.com
HQ: 5 Sylvan Way Ste 300 Parsippany, 07054-3813 New Jersey
Related News